SCHEMBL19786048

SCHEMBL19786048

Cc1cccc(CCc2cccc(Cc3cncc(C)n3)n2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.40
HRH1 P35367 1/20 0.40
NOS2 P35228 2/20 0.39
NOS1 P29475 1/20 0.39
KCNH2 Q12809 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
MBOAT4 Q96T53 1/20 0.36
MPO P05164 1/20 0.36
HSD17B3 P37058 1/20 0.36
CCR1 P32246 1/20 0.35
CCR8 P51685 1/20 0.35
IRAK4 Q9NWZ3 2/20 0.33
NOS3 P29474 1/20 0.33
CYP2A6 P11509 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KDM1A O60341 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10144469 0.82 KCNH2 (0.54) NOS2NOS1KCNH2SMN1; SMN2MBOAT4
SCHEMBL30201993 0.80 CCR1 (0.52) NOS2NOS1KCNH2SMN1; SMN2MBOAT4
SCHEMBL14082023 0.80 CCR1 (0.52) CYP2D6NOS2KCNH2SMN1; SMN2MBOAT4
SCHEMBL24916774 0.80 CCR1 (0.52) NOS2NOS1KCNH2SMN1; SMN2MBOAT4
SCHEMBL24299173 0.75 MPO (0.41) NOS2NOS1KCNH2SMN1; SMN2MBOAT4
SCHEMBL10834770 0.75 CYP2D6 (0.38) CYP2D6HRH1NOS2NOS1NOS3
SCHEMBL13562461 0.72 SCD (0.44) CYP2D6HRH1SMN1; SMN2
SCHEMBL427622 0.70 KCNH2 (0.52) NOS2NOS1KCNH2SMN1; SMN2MBOAT4
SCHEMBL17656042 0.69 MBOAT4 (0.44) NOS2SMN1; SMN2MBOAT4MPOCCR1
SCHEMBL1563917 0.69 KCNH2 (0.73) NOS2NOS1KCNH2SMN1; SMN2CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10017507-B2 Diaza-benzofluoranthrene compounds HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARMACEUTICAL FACTORY (CN) 2018-07-10 US disclosed
US-20180016270-A1 DIAZA-BENZOFLUORANTHRENE COMPOUNDS HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARMACEUTICAL FACTORY (CN) 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180016270-A1 DIAZA-BENZOFLUORANTHRENE COMPOUNDS DDT, CYP3A43, CYP19A1 CYP2D6 16/4885HRH1 1552/4885NOS2 3402/4885
US-10017507-B2 Diaza-benzofluoranthrene compounds DDT, CYP3A43, CYP19A1 CYP2D6 16/4885HRH1 1552/4885NOS2 3402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.